China Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Key Highlights

• The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
• The Chinese biotechnology market recorded revenues of $63.4 billion in 2023, representing a compound annual growth rate (CAGR) of 10.4% between 2018 and 2023.
• The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $34.9 billion, equivalent to 55.1% of the market's overall value.
• The Chinese biotechnology market is experiencing growth due to innovation and potential therapeutic developments. China’s biotechnology market places a strong emphasis on research and development, and numerous businesses make large investments in this field. For instance, in August 2023, China introduced new attempts to attract foreign investors, promising to boost R&D in the biotech industry and "fast-track" cross-border data flows.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts

Reasons to Buy

• What was the size of the China biotechnology market by value in 2023?
• What will be the size of the China biotechnology market in 2028?
• What factors are affecting the strength of competition in the China biotechnology market?
• How has the market performed over the last five years?
• Who are the top competitors in China's biotechnology market?